IND

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Bio & Pharma Hanmi Pharm to develop obesity drug customized for S.Korean

South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...

Bio & Pharma Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Fiber & Textile Kolon Ind expands tire cord fabric plant in Vietnam

Kolon Industries Inc. has expanded the capacity of its polyester tire cord fabric plant in Vietnam, the South Korean company said on Wednesday.The f...

Aerospace & Defense Korean Aerospace Ind.'s shares soar on Poland export hopes

Korea Aerospace Industries Ltd. (KAI), South Korea’s military aircraft manufacturer, is emerging a winner in South Korea’s sagging stock...

Corporate restructuring Dongwon restructuring plan faces shareholder backlash

A South Korean leading seafood and logistics conglomerate Dongwon Group’s corporate restructuring plan hit a roadblock as institutional invest...